22- and 20 kDa-human growth hormones bind to different sites within certain cellular receptors

Growth Hormone and IGF Research

Volumn 13, Issue 6, 2003, Pages 353-360

  Longhi, Silvia A ^a   Cortés, María M ^a   Retegui, Lilia A ^a  

^a Instituto de Quimica y Fisicoquimica Biologicas Buenos Aires   (Argentina)

Author keywords

20 kDa hGH; 22 kDa hGH; Growth hormone receptors; Human liver; Human placenta; Prolactin receptors; Receptor binding sites

Indexed keywords

CELL RECEPTOR; GROWTH HORMONE ANTIBODY; GROWTH HORMONE RECEPTOR; HUMAN GROWTH HORMONE; ISOPROTEIN; MONOCLONAL ANTIBODY; PROLACTIN RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; HORMONE BINDING; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LIVER MEMBRANE; LIVER MICROSOME; NONHUMAN; PLACENTA; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; TISSUE SPECIFICITY;

EID: 0344739871     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(03)00125-4     Document Type: Article

References (44)

1. S.A. Longhi, M.E. Miranda, M.G. Gobet, L.A. Retegui, A monoclonal antibody recognizing an epitope shared by receptors for growth hormone, prolactin, interleukin 2 and interleukin 6, Mol. Cell. Biochem. 195 (1999) 235-243.
2. S.A. Longhi, C. Wolfenstein-Todel, K. Gómez, M.E. Miranda, L.A. Retegui, Ovine placental lactogen and human growth hormone bind to different regions of the same receptors, Growth Horm. IGF Res. 9 (1999) 157-164, ghir.1999.0107.
3. S.A. Longhi, V.C. Blank, L.P. Roguin, M. Cristodero, L.A. Retegui, Relative localization of the prolactin receptor binding sites for lactogenic hormones, Growth Horm. IGF Res. 11 (2001) 324-328, doi:10.1054/ghir.2001.0234.
4. F.M. DeNoto, D.D. Moore, H.M. Goodman, Human growth hormone DNA sequence and mRNA structure: possible alternative splicing, Nucleic Acids Res. 9 (1981) 3719-3730.
5. U.J. Lewis, L.F. Bonewald, L.J. Lewis, The 20 000-dalton variant of human growth hormone: location of the amino acid deletions, Biochem. Biophys. Res. Commun. 92 (1980) 511-516.
6. U.J. Lewis, J.T. Dunn, L.F. Bonewald, B.K. Seavey, W.P. Vanderlaan, A naturally occurring structural variant of human growth hormone, J. Biol. Chem. 253 (1978) 2679-2687.
7. T.A. Stewart, S. Clift, S. Pitts-Meek, L. Martin, T.G. Terrell, D. Liggitt, H. Oakley, An evaluation of the functions of 22-kilodalton (kDa), the 20-kDa, and the N-terminal polypeptide forms of human growth hormone using transgenic mice, Endocrinology 130 (1992) 405-414.
8. J.L. Kostyo, C.M. Cameron, K.C. Olson, A.J. Jones, R-C. Pai, Biosynthetic 20-kilodalton methionyl-human growth hormone has diabetogenic and insulin-like activities, Proc. Natl. Acad. Sci. USA 82 (1985) 4250-4253.
9. M. Ader, T. Agajanian, D.T. Finegood, R.N. Bergman, Recombinant deoxyribonucleic acid-derived 22 kDa- and 20 kDa-human growth hormone generate equivalent diabetogenic effects during chronic infusion in dogs, Endocrinology 120 (1987) 725-731.
10. S. Takahashi, Y. Shiga, N. Satozawa, M. Hayakawa, Diabetogenic activity of 20 kDa human growth hormone (20 kDa-hGH) and 22 kDa-hGH in rats, Growth Horm. IGF Res. 11 (2001) 110-116, doi:1054/ghir.2001.0198.
11. M. Ishikawa, N. Hiroi, T. kDaamioka, T. Tanaka, T. Tachibana, H. Ishikawa, Y. Miyachi, Metabolic effects of 20 kDa and 22 kDa human growth hormones on adult male spontaneous dwarf rats, Eur. J. Endocrinol. 145 (2001) 791-797.
12. N. Satozawa, kDa Takezawa, T. Miwa, S. Takahashi, M. Hayakawa, H. Ooka, Differences in the effects of 20 kDa- and 22 kDa-hGH on water retention in rats, Growth Horm. IGF Res. 10 (2000) 187-192.
13. L.G. Frigeri, S.M. Peterson, U.J. Lewis, The 20 000-Dalton structural variant of human growth hormone: lack of some early insulin-like effects, Biochem. Biophys. Res. Commun. 91 (1979) 778 782.
14. J. Smal, J. Closset, G. Hennen, P. De Meyts, Receptor binding properties and insulin-like effects of human growth hormone and its 20 kDa-variant in rat adipocytes, J. Biol. Chem. 262 (1987) 11071-11079.
15. Y. Ohmae, H. Yano, S. Umezawa, T. Tanaka, I. Hibi, C. Miyamoto, Y. Furuichi, Biological activities of synthesized 20 kDa and 22 kDa hGH in Nb2 bioassay and IM-9 radioreceptor assay, Endocrinol. Jpn. 36 (1989) 9-13.
16. M.T. Dattani, P.C. Hindmarsh, C.G.D. Brook, I.C.A.F. Robinson, T. Weir, N.J. Marshall, Enhancement of growth hormone bioactivity by zinc in the eluted stain assay system, Endocrinology 133 (1993) 2803-2808.
17. D.S. Wang, kDa Sato, H. Demura, Y. Kato, N. Maruo, Y. Miyachi, Osteo-anabolic effects of human growth hormone with 22 kDa- and 20 kDa Daltons on human osteoblast-like cells, Endocrinol. J. 46 (1999) 125-132.
18. M.B. Sigel, N.A. Thorpe, M.S. kDaobrin, U.J. Lewis, W.P. Vanderlaan, Binding characteristics of a biologically active variant of human growth hormone (20 kDa) to growth hormone and lactogen receptors, Endocrinology 108 (1981) 1600-1603.
19. L. Wohnlich, W.V. Moore, Binding of a variant of growth hormone to liver plasma membranes, Horm. Metab. Res. 14 (1982) 138-141.
20. J. McCarter, M.A. Shaw, L.A. Winer, G. Baumann, The 20 000 Da variant of human growth hormone does not bind to growth hormone receptors in human liver, Mol. Cell. Endocrinol. 73 (1990) 11-14.
21. J. Smal, J. Closset, G. Hennen, P. De Meyts, The receptor binding properties of the 20 kDa variant of human growth hormone explain its discrepant insulin-like and growth promoting activities, Biochem. Biophys. Res. Commun. 134 (1986) 159-165.
22. C. Carter Su, J. Schwartz, L.S. Smit, Molecular mechanism of growth hormone action, Annu. Rev. Physiol. 58 (1996) 187-207.
23. M. Wada, M. Ikeda, Y. Takahashi, N. Asada, K.T. Chang, M. Takahashi, M. Honjo, The full agonistic effect of recombinant 20 kDa human growth hormone (hGH) on CHO cells stably transfected with hGH receptor cDNA, Mol. Cell. Endocrinol. 133 (1997) 99-107.
24. M. Wada, H. Uchida, M. Ikeda, B. Tsunekawa, N. Naito, S. Banba, E. Tanaka, Y. Hashimoto, M. Honjo, The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22 kDa hGH in the complex formation with cell surface hGH receptor and hGH-binding protein circulating in human plasma, Mol. Endocrinol. 12 (1998) 146-156.
25. 125I to high specific activity, Biochem. Biophys. Acta 251 (1971) 363-369.
26. M.M. Mazza, L.A. Retegui, The antigenic topography of human growth hormone, Mol. Immunol. 26 (1989) 231-240.
27. R.C. Aguilar, L.A. Retegui, M-C. Postel-Vinay, L.P. Roguin, Allosteric effects of monoclonal antibodies on human growth hormone, Mol. Cell. Biochem. 136 (1994) 35-42.
28. L.P. Roguin, R.C. Aguilar, L.A. Retegui, Monoclonal antibodies to human growth hormone modulate its biological properties, Mol. Immunol. 32 (1995) 399-405.
29. O.H. Lowry, N.J. Rosebrough, A. Farr, R.J. Randall, Protein measurements with the folin phenol reagent, J. Biol. Chem. 193 (1951) 265-275.
30. T. Tanaka, R.P.C. Shiu, P.W. Gout, C.T. Beer, R.L. Noble, H.G. Friesen, A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum, J. Clin. Endocrinol. Metab. 51 (1980) 1058-1063.
31. U.K. Laemli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227 (1970) 680-685.
32. B.C. Cunnigham, J.A. Wells, High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis, Science 244 (1989) 1081-1085.
33. W. Somers, M. Ultsch, A.M. De Vos, A.A. Kossiakoff, The X-ray structure of a growth hormone-prolactin receptor complex, Nature 372 (1994) 478-481.
34. B.C. Cunningham, S. Bass, G. Fuh, J.A. Wells, Zinc mediation of the binding of human growth hormone to the human prolactin receptor, Science 250 (1990) 1709-1712.
35. B.C. Cunningham, J.A. Wells, Rational design of receptor-specific variants of human growth hormone, Proc. Natl. Acad. Sci. USA 88 (1991) 3407-3411.
36. B. Tsunekawa, M. Wada, M. Ikeda, H. Uchida, N. Naito, M. Honjo, The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22 kDa hGH in the effect on human prolactin receptor, Endocrinology 140 (1999) 3909-3918.
37. V. Goffin, K.T. Shiverick, P.A. Kelly, J.A. Martial, Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen and related proteins in mammals, Endocriol. Rev. 17 (1996) 385-410.
38. D.W. Leung, S.A. Spencer, G. Cachaines, G. Hammonds, C. Collins, W.J. Henzel, R. Barnard, M.J. Waters, W.I. Wood, Growth hormone receptor and serum binding protein: purification, cloning and expression, Nature 330 (1987) 537-543.
39. M. Urbanek, J.N. MacLeod, N.E. Cooke, S.A. Liebhaber, Expression of a human growth hormone (hGH) receptor isoform is predicted by tissue-specific alternative splicing of exon 3 of the hGH receptor gene transcript, Mol. Endocrinol. 6 (1992) 279-287.
40. N. Esposito, P. Paterlini, P.A. Kelly, M-C. Postel-Vinay, J. Finidori, Expression of two isoforms of the human growth hormone receptor in normal liver and hepatocarcinoma, Mol. Cell. Endocrinol. 103 (1994) 13-20.
41. M.L. Stallings-Mann, R.L. Ludwiczak, K.W. Klinger, F. Rottman, Alternative splicing of exon3 of the human growth hormone receptor is the result of an unusual genetic polymorphism, Proc. Natl. Acad. Sci. USA 93 (1996) 12394-12399.
42. J-F. Hocquette, M-C. Postel-Vinay, C. Kayser, B. de Hemptinne, A. Amar-Costesec, The human liver growth hormone receptor, Endocrinology 125 (1989) 2167-2174.
43. G. Bauman, Growth hormone binding protein: biochemical characterization and assay, Acta Endocrinol. (Copenh) 124 (1990) 21-26.
44. M. Urbanek, J.E. Russel, N.E. Cooke, S.A. Liebhaber, Functional characterization of the alternatively spliced, placental human growth hormone receptor, J. Biol. Chem. 268 (1993) 19022-19025.